Atlas Trials

Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk

Clinical trial NCT05402579 · COMPLETED

Trial details

NCT number
NCT05402579
Sponsor
Mount Sinai Hospital, Canada
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Type 2DKADiabetic Ketoacidosis
Start date
2022-07-29
Primary completion
2025-01-20
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.